LICHEN SCLEROSUS – EPIDEMIOLOGY, TREATMENT, IMPACT ON QUALITY OF LIFE AND EMERGING THERAPEUTIC APPROACHES - A REVIEW
Authors:
- Martyna KadłubańskaMKMartyna Kadłubańska
- Aleksandra Anna KulsAKAleksandra Anna Kuls
- Sonia ZembrzuskaSZSonia Zembrzuska
- Nicole BulińskaNBNicole Bulińska
- Bogusław PabisBPBogusław Pabis
- Zofia SinczakZSZofia Sinczak
- Aleksandra Zofia SobolASAleksandra Zofia Sobol
- Justyna Maria WiktorowiczJWJustyna Maria Wiktorowicz
- Stanisław BajerskiSBStanisław Bajerski
- Anna Maria KowalskaAKAnna Maria Kowalska
Open Access
- 30 June 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Abstract
Lichen sclerosus (LS) is a chronic, inflammatory skin disease with a complex, multifactorial etiology, encompassing immunological, genetic, hormonal, and environmental factors. The disease most commonly affects the anogenital region, leading to characteristic porcelain-white, atrophic plaques that can cause anatomical deformities, scarring, and impairments in sexual and urological function. LS symptoms are variable and include pruritus, pain, dyspareunia, urinary and bowel disturbances, as well as extragenital lesions in keratotic, bullous, or annular forms. The prevalence of LS differs between children and adults, and diagnostic delays can range from several months up to five years, increasing the risk of complications, including squamous cell carcinoma of the genital organs. Diagnosis is primarily based on clinical examination, dermoscopy, and, in ambiguous cases, skin biopsy. Standard treatment includes topical glucocorticosteroids, with the possibility of maintenance therapy and adjunctive approaches such as calcineurin inhibitors, laser therapies, or systemic acitretin. Due to the chronic course of the disease and its impact on quality of life, patient care should be multidisciplinary, incorporating psychological support, sexual counseling and patient education. The aim of this study is to provide a comprehensive overview of the clinical manifestations, diagnostic methods, therapeutic strategies, and consequences of LS for patient functioning. Emphasizing the importance of early diagnosis, monitoring of lesions, and patient education may contribute to improved treatment outcomes and quality of life for affected individuals.Keywords
This publication has 23 references indexed in Scilit:
- Clinical presentations and complications of lichen sclerosus: A systematic reviewJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024
- The impact of genital lichen sclerosus in men and women on quality of life: a prospective cohort studyInternational Journal of Women's Dermatology, 2024
- Vulvar Lichen SclerosusJAMA Dermatology, 2022
- Extragenital lichen sclerosus: A comprehensive reviewAustralasian Journal of Dermatology, 2022
- Comparison of lichen sclerosus in boys and girls: A systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosisPediatric Dermatology, 2022
- Lichen Sclerosus: Why Do Most Women Struggle With Their Diagnosis?Journal of Obstetrics and Gynaecology Canada, 2022
- Lichen sclerosus among women in the United StatesInternational Journal of Women's Dermatology, 2020
- Dermoscopy of Morphea and Cutaneous Lichen Sclerosus: Clinicopathological Correlation Study and Comparative AnalysisDermatology, 2017
- A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosusJournal of the American Academy of Dermatology, 2014
- Lichen sclerosusClinical and Experimental Dermatology, 2003